Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | — | 2 | — | — | — | 2 |
Small cell lung carcinoma | D055752 | — | — | — | 2 | — | — | — | 2 |
Colorectal neoplasms | D015179 | — | — | — | 1 | — | — | — | 1 |
Recurrence | D012008 | — | — | — | 1 | — | — | — | 1 |
Brain neoplasms | D001932 | EFO_0003833 | C71 | — | 1 | — | — | — | 1 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 1 | — | — | — | 1 |
Non-small-cell lung carcinoma | D002289 | — | — | — | 1 | — | — | — | 1 |
Lung neoplasms | D008175 | HP_0100526 | C34.90 | — | 1 | — | — | — | 1 |
Drug common name | FIRTECAN PEGOL |
INN | firtecan pegol |
Description | Firtecan pegol is a small molecule pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Small molecule |
Drug class | PEGylated compounds, covalent attachment of macrogol (polyethylene glycol) polymer; antineoplastics (camptothecin derivatives) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL4594234 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | WC4978T687 (ChemIDplus, GSRS) |